Generic Insulin
Some state governors and other lawmakers want the Food and Drug Administration to speed up the approval of generic insulin. According to a report in the New York Times, a generic version of injectable insulin could reduce the cost of diabetes management by up to 25 percent.
Read moreMore information on "Generic Insulin"
From Our Experts
I is for Insulin: Insulin Treatment and Weight Control- Diabetes
Like hypos last week, insulin is in the news. Considering that nothing is better at causing hypos than insulin is, they are connected in... Read more »
Insulin is a Good Choice for Treating Diabetes
I recently received an e-mail from a patient, describing their multiple diabetes medications now and previously, and ending with the... Read more »
Diabetes & Fashion: Identification, Insulin Pump Friendly...
After spending more than five hours researching and downloading journal articles to write the last blog, I decided to lighten it up a bit.... Read more »
Adjusting Insulin Dosages when You're Stressed Lowers...
Did you know that being mentally/physically stressed can have a huge impact on your blood sugars and your insulin sensitivity? I had a... Read more »
Multiple Daily Insulin Injections vs. the Insulin Pump: Where Are We...
I am back from vacation in Ithaca, New York, and am catching up with my journal reading. The July 22, 2010, lead article in the New England... Read more »
From Our Sources
Glucotrol goes generic
Actavis Pharmaceuticals has released a generic formula of Pfizer's diabetes medication Glucotrol XL (glipizide) in the United States. Glipizide is... Read more »
Drugmaker recalls dozens of generic drugs
Drugmaker Ethex Corporation is recalling dozens of drugs, including generic formulas of OxyContin, Toprol XL, and Norvasc, because of potential... Read more »
FDA approves generic Prilosec
The Indian drug company Dr Reddy's Laboratories Ltd says that the U.S. Food and Drug Administration has approved a generic, over-the-counter version... Read more »
FTC: Generic biologic meds delay is too long
Officials at the Federal Trade Commission (FTC) say the 12- to 14-year patent-protection period given to biologic medications is too long to "promote... Read more »
Clinical trial: Comparison of effectiveness of biphasic insuli...
This is a study to compare the effectiveness of biphasic insulin aspart 70/30 versus insulin glargine in patients with Type 2 diabetes. This national... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
